Last A$0.28 AUD
Change Today +0.005 / 1.82%
Volume 115.0K
TIS On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:27 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

tissue therapies ltd (TIS) Snapshot

Open
A$0.28
Previous Close
A$0.28
Day High
A$0.28
Day Low
A$0.28
52 Week High
09/15/14 - A$0.47
52 Week Low
12/23/13 - A$0.22
Market Cap
73.7M
Average Volume 10 Days
69.8K
EPS TTM
A$-0.03
Shares Outstanding
263.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TISSUE THERAPIES LTD (TIS)

Related News

No related news articles were found.

tissue therapies ltd (TIS) Related Businessweek News

No Related Businessweek News Found

tissue therapies ltd (TIS) Details

Tissue Therapies Limited, a biomedical technology company, researches, develops, and commercializes biomedical technologies for chronic wound healing and tissue regeneration worldwide. The company commercializes VitroGro ECM, a biomimetic scaffold comprising a synthetic extracellular matrix protein that replaces the degraded matrix of a hard to heal wounds for the patients and the healthcare providers. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns, as well as treatments for psoriasis, scar prevention, and various cancers, such as breast, colon, and prostate. Tissue Therapies Limited is headquartered in Brisbane, Australia.

tissue therapies ltd (TIS) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$334.8K
Chief Financial officer and Company Secretary
Total Annual Compensation: A$174.4K
Compensation as of Fiscal Year 2014.

tissue therapies ltd (TIS) Key Developments

Tissue Therapies Ltd. Appoints Timothy Hughes as Non-Executive Director

Tissue Therapies Limited announced the strengthening of the Board with the addition of a new non-executive director, Mr. Timothy Hughes. Mr. Hughes has significant experience in investment banking and finance from the senior positions he has held with Rothschilds Australia and within the superannuation industry and his experience as a director of various companies including Alchemia Ltd, Value Capital Management Pty Ltd. and South Endeavour Pty Ltd.

Tissue Therapies Ltd., Annual General Meeting, Oct 07, 2014

Tissue Therapies Ltd., Annual General Meeting, Oct 07, 2014., at 10:30 E. Australia Standard Time. Location: McCullough Robertson, Level 11. Agenda: To consider the directors' remuneration report; to consider the elections of directors; to approve the issue of options to director; to approve the previous allotment and issue of shares under a placement; to approve the previous allotment and issue of shares to priority sub underwriter; to approve the previous allotment and issue of shares for consultancy services; and to approve the additional capacity to issue shares.

Tissue Therapies Ltd. Announces Audited Consolidated Earnings Results for the Year Ended June 30, 2014

Tissue Therapies Ltd. announced audited consolidated earnings results for the year ended June 30, 2014. For the year, the company reported total revenue of AUD 229,069 compared to AUD 281,224 a year ago. Loss before income tax was AUD 7,333,628 compared to AUD 6,051,070 a year ago. Net loss from continuing operations was AUD 6,829,591 compared to AUD 5,740,094 a year ago. Net loss attributable to members of the company was AUD 6,829,591 compared to AUD 5,740,094 a year ago. Basic and diluted loss per share were 2.82 cents compared to 3.09 cents a year ago. Net cash used in operating activities was AUD 7,074,363 compared to AUD 9,255,413 a year ago. Payments for property, plant and equipment was AUD 17,289 compared to AUD 19,743 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TIS:AU A$0.28 AUD +0.005

TIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TIS.
View Industry Companies
 

Industry Analysis

TIS

Industry Average

Valuation TIS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TISSUE THERAPIES LTD, please visit www.tissuetherapies.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.